Literature DB >> 2654032

The absolute oral bioavailability of selected drugs.

W K Sietsema1.   

Abstract

Oral bioavailability is best defined as the rate and extent to which an active drug substance is absorbed and becomes available to the general circulation. This concept is discussed, along with several popular methods for determining absolute oral bioavailability. The absolute oral bioavailability of numerous drugs is reviewed and interspecies comparisons are made. In general, absolute oral bioavailability does not correlate well between species, though relative comparisons might be made.

Mesh:

Year:  1989        PMID: 2654032

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  25 in total

1.  Rate-limited steps of human oral absorption and QSAR studies.

Authors:  Yuan H Zhao; Michael H Abraham; Joelle Le; Anne Hersey; Chris N Luscombe; Gordon Beck; Brad Sherborne; Ian Cooper
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Predicting drug pharmacokinetic properties using molecular interaction fields and SIMCA.

Authors:  Philippa R N Wolohan; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2003-01       Impact factor: 3.686

3.  Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention.

Authors:  Geoffrey W Birrell; Gavin D Heffernan; Guy A Schiehser; John Anderson; Arba L Ager; Pablo Morales; Donna MacKenzie; Karin van Breda; Marina Chavchich; Laura R Jacobus; G Dennis Shanks; David P Jacobus; Michael D Edstein
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 4.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  The prediction of human oral absorption for diffusion rate-limited drugs based on heuristic method and support vector machine.

Authors:  H X Liu; R J Hu; R S Zhang; X J Yao; M C Liu; Z D Hu; B T Fan
Journal:  J Comput Aided Mol Des       Date:  2005-01       Impact factor: 3.686

6.  Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.

Authors:  Clarence N Ahlem; Michael R Kennedy; Theodore M Page; Christopher L Reading; Steven K White; John J McKenzie; Phaedra I Cole; Dwight R Stickney; James M Frincke
Journal:  Int J Clin Exp Med       Date:  2011-04-23

7.  Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship.

Authors:  C W Andrews; L Bennett; L X Yu
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

8.  Comparison of oral absorption and bioavailablity of drugs between monkey and human.

Authors:  Win L Chiou; Paul W Buehler
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

9.  Species difference in intestinal absorption mechanism of etoposide and digoxin between cynomolgus monkey and rat.

Authors:  T Nishimura; Y Kato; N Amano; M Ono; Y Kubo; Y Kimura; H Fujita; A Tsuji
Journal:  Pharm Res       Date:  2008-07-15       Impact factor: 4.200

10.  Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

Authors:  Gary W Caldwell; John A Masucci; Zhengyin Yan; William Hageman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.